Market Research Industry Reports

Global Pharmaceutical & Biotechnology Outlook 2013: India Pharma

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
India pharma rode on the wave of bunched up patent expiries in the US with many Para IV launches in 2012. In addition, it also benefited from the continuing high teen growth of Indian pharma market. With patent expiries in the US dwindling from $30b in 2012 to $10b in 2013 (small molecules), Indian generic companies will now need to focus on complex generics that offer sustainability of earnings. Locally acting drugs and targeted drug delivery products make up for the bulk of complex formulation generics. We have analyzed this space and have provided a fairly comprehensive list of products falling under these categories indicating that topical drugs remains the most near term opportunity for generics. Inhalers offer the most lucrative opportunity, though not before 2016.

Our growth outlook on Indian market continues to remain optimistic with 15-18% growth. This is based on the silent reforms in India that started with implementation of a strict GMP (Good Manufacturing Practices) in 2005, continued with implementation of GLP (Good Laboratories Practices) in 2011 and now the bar coding norms at primary and secondary levels. All these continue to put pressure on the very small manufacturer ultimately leading to industry consolidation something that augurs well for worlds most fragmented pharma market. We do not see any negative impact due to the newly announced National Pharma Pricing Policy (NPPP) due to its emphasis on market price based pricing policy.

Our top pick remains Sun Pharma as it remains the best positioned to tide over the patent cliff with its latest acquisitions, DUSA and URL Pharma. A strong balance sheet further allows it to acquire more such high value targets. We also recommend Natco Pharma for its focus on complex generics like Copaxone, Revlimid and Tamiflu. Besides this, its domestic market strategy targeted at gaining Compulsory License on high value oncology products too remains lucrative.
Key Topics Covered
Branded Liposomal Drugs and Generic Approvals in US
2. Branded Colon Targeted Drugs and Generic Approvals in US
3. Branded Transdermal Drugs and Generic Approvals in US
4. Branded Topical Drugs and Generic Approvals in US
5. Acquisitions in Dermatology Segment
6. Branded Inhalation Drugs and Generic Approvals in US
7. History of Wholesale Price Indices in India
8. Ciplas Inhaler Portfolio Approved Products and Competitive Landscape
9. Ciplas Inhaler Portfolio Pipeline Products and Competitive Landscape

List Of Tables

N/A

List Of Figures

Branded Liposomal Drugs and Generic Approvals in US
2. Branded Colon Targeted Drugs and Generic Approvals in US
3. Branded Transdermal Drugs and Generic Approvals in US
4. Branded Topical Drugs and Generic Approvals in US
5. Acquisitions in Dermatology Segment
6. Branded Inhalation Drugs and Generic Approvals in US
7. History of Wholesale Price Indices in India
8. Ciplas Inhaler Portfolio Approved Products and Competitive Landscape
9. Ciplas Inhaler Portfolio Pipeline Products and Competitive Landscape

Phenylketonuria (PKU) Global Clinical Trials Review, H1, 2018

Phenylketonuria (PKU) Global Clinical Trials Review, H1, 2018GlobalDatas clinical trial report, Phenylketonuria (PKU) Global Clinical Trials Review, H1, 2018 provides an overview of Phenylketonuria (PKU) clinical trials scenario. This report

USD 2500View Report

Pharyngitis Global Clinical Trials Review, H1, 2018

Pharyngitis Global Clinical Trials Review, H1, 2018GlobalDatas clinical trial report, Pharyngitis Global Clinical Trials Review, H1, 2018 provides an overview of Pharyngitis clinical trials scenario. This report provides top line

USD 2500View Report

Global Pharmaceutical Packaging Equipment Market – By Product Type (Solids, Semi-Solids, Liquids), By Package Type (Primary, Secondary, Labeling and Serialization), By Region, By Country: Opportunities and Forecasts (2018-2023)

Executive A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Pharmaceutical Packaging

USD 2400View Report

Global Pharmaceutical Desiccant Market – Trends & Forecast, 2016-2027

Report Description IntroductionAccording to IMS Market prognosis, the U.S. is leading the market in terms of pharmaceutical spending per capita in 2016, followed by Japan and Canada. The government of

USD 4450View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 2500
  • Site Licence    USD 5000
  • Enterprisewide Licence    USD 7500
$ 2500

Reports Details

Published Date : Jan 2013
No. of Pages :50
Country :Global
Category :Healthcare
Publisher :MP Advisors
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube